LYRA THERAPEUTICS INC shareholders Q3 2023

LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 46 filers reported holding LYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

LYRA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 2,780,261$10,870,8213.33%
Perceptive Advisors 12,757,562$49,882,0671.66%
Nantahala Capital Management 4,050,218$15,836,3521.35%
PURA VIDA INVESTMENTS, LLC 1,413,242$5,525,7761.04%
Ikarian Capital, LLC 1,254,384$4,904,6410.59%
Parkman Healthcare Partners LLC 625,056$2,443,9690.45%
VR Adviser, LLC 924,170$3,613,5050.38%
Soleus Capital Management, L.P. 592,417$2,316,3500.21%
ARMISTICE CAPITAL, LLC 1,550,000$6,060,5000.09%
Clearline Capital LP 119,128$465,7900.04%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 30,000$117,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 234,003$914,9520.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 141,800$554,4380.01%
Virtu Financial LLC 19,618$770.01%
Alyeska Investment Group, L.P. 240,723$941,2270.01%
Ensign Peak Advisors, Inc 301,533$1,178,9940.00%
Alyeska Investment Group, L.P. 130,839$511,5800.00%
LETKO, BROSSEAU & ASSOCIATES INC 31,900$124,7290.00%
Ameliora Wealth Management Ltd. 750$2,9250.00%
Citadel Advisors 2,848,564$11,137,8850.00%
External links

This page lists LYRA THERAPEUTICS INC's shareholders in Q3 2023. To view LYRA THERAPEUTICS INC's shareholder history, click here.